76
Participants
Start Date
November 1, 2021
Primary Completion Date
March 13, 2023
Study Completion Date
December 22, 2023
VT-X7 Treatment System with Tobramycin Sulfate
Seven-day local antibiotic irrigation with tobramycin sulfate via the VT-X7 Knee or Hip Spacer.
Standard of Care
Forty-two days (minimum) systemic antibiotic administration adjuvant to two-stage exchange arthroplasty with temporary antibiotic-impregnated cement spacer per standard of care. Antibiotics will be selected by treatment provider and administered in accordance with national and local treatment guidelines.
Two-stage exchange arthroplasty
Stage 1 consists of surgical removal of the infected prosthesis, debridement, and implantation of a temporary spacer. Stage 2 surgery consists of explantation of the temporary spacer, debridement, and implantation of a permanent prosthesis, followed by systemic administration of postoperative antibiotics for 42 days (inclusive) to 90 days (inclusive).
VT-X7 Treatment System with Vancomycin Hydrochloride
Seven-day local antibiotic irrigation with vancomycin hydrochloride via the VT-X7 Knee or Hip Spacer.
New York University, New York
Columbia, New York
Rothman Orthopaedic Institute, Philadelphia
VA Medical Center, Washington D.C.
UVA Orthopedics Center, Charlottesville
OrthoCarolina Research Institute, Inc, Charlotte
University of Florida, Gainesville
Cleveland Clinic, Weston
University of Kentucky, Lexington
Ohio State University, Columbus
Cleveland Clinic, Cleveland
Covenant Medical Center, Saginaw
Integris Southwest Medical Center, Oklahoma City
Texas Health Presbyterian, Plano
University of Utah, Salt Lake City
University of Arizona, Phoenix, Phoenix
Harbor-UCLA Medical Center, Torrance
Lead Sponsor
Osteal Therapeutics, Inc.
INDUSTRY